title: Hereditary Pancreatic Cancer Syndromes.
abstract: Despite decades of scientific and clinical research, pancreatic ductal adenocarcinoma (PDAC) remains a lethal malignancy. The clinical and pathologic features of PDAC, specifically the known environmental and genetic risk factors, are reviewed here with special emphasis on the hereditary pancreatic cancer (HPC) syndromes. For these latter conditions, strategies are described for their identification, for primary and secondary prevention in unaffected carriers, and for disease management in affected carriers. Nascent steps have been made toward personalized medicine based on the rational use of screening, tumor subtyping, and targeted therapies; these have been guided by growing knowledge of HPC syndromes in PDAC.
authors.affiliation: Division of General Surgery, Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Ashton A
authors.initials: AA
authors.lastname: Connor
authors.affiliation: Division of General Surgery, Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: steven.gallinger@uhn.ca.
authors.forename: Steven
authors.initials: S
authors.lastname: Gallinger
mesh_terms: D019468:Disease Management; D020022:Genetic Predisposition to Disease; D006801:Humans; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis / Q000235:genetics*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000235:genetics*; D018570:Risk Assessment
keywords: Adenocarcinoma; Cancer; Exocrine; Familial; Genetics; Hereditary; Pancreas; Syndrome